Sheng-Yong Yang, Dr., Professor of the State Key Laboratory of Biotherapy, West China Hospital, Sichuan University (Sichuan, China). Dr. Yang obtained his PhD degree from Sichuan University in 1999. After that, he did his postdoc research in Hongkong University of Science and Technology from 1999-2001. In 2002-2005, he joined Prof. Tom Ziegler’s group (University of Calgary, Alberta, Canada) as a research scientist. In the end of 2005, he was recruited as a professor of the State Key Laboratory of Biotherapy, West China Hospital, Sichuan University. His research spans methodology of computer aided drug discovery (CADD), and research and development (R&D) of small molecule targeted drugs. Up to now, Dr. Yang has published more than 160 papers in international journals, including JACS, Angew chem Int Ed, Leukemia, Drug Disc Today, JMC, Clin Cancer Res, and JCIM et al. He has developed a number of CADD methods, including PhDD, RASA, SCADMET, GA-CG-SVM, ID-score, and TarPred. Five drug candidates have been transferred to pharmaceutical companies, and one has entered clinical trials. Dr. Yang was awarded the Cheung Kong Scholar of the Ministry of Education (MOE), and won the Life and Chemistry Research Award of Wuxi Pharma Tech in 2012. He received the National Science Fund for Distinguished Young Scholars in 2013.

His research interests include methodology of computer aided drug discovery (CADD), and research and development (R&D) of small molecule targeted drugs.